Tough life being a biotech. Cap raising must be a very tough gig. Discount and incentives to make sure it works for the company and in the end us as shareholders are in our interest.
What did you make of the company update. The clarification for expansion of the testing makes this a whole new world of potential.
Not suggesting do as I do. Tried buying at 1.9 but as usual paid more (2.0) Averaging and adding to this one is fine with me.
Ann: Capital Raising, page-32
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.015(3.13%) |
Mkt cap ! $51.85M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.0¢ | 46.0¢ | $95.71K | 205.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.20pm 11/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |